Search Results - "Kayaleh, O R"

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma by El-Khoueiry, A B, Rankin, C, Siegel, A B, Iqbal, S, Gong, I-Y, Micetich, K C, Kayaleh, O R, Lenz, H-J, Blanke, C D

“…Background: Gallbladder cancers and cholangiocarcinomas make up a heterogenous group of tumours with a poor prognosis in advanced stages. On the basis of…”
Get full text

A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer by Xiong, H. Q., Hess, K. R., Kayaleh, O. R., Goodwin, J. W., Banerjee, T., Sinclair, S. S., Fisch, M. J., Wolff, R. A., Abbruzzese, J. L.

“…Abstract only…”
Get full text